Deutsche Bank Aktiengesellschaft Begins Coverage on RXO (NYSE:RXO)

Deutsche Bank Aktiengesellschaft initiated coverage on shares of RXO (NYSE:RXOFree Report) in a research report sent to investors on Friday morning, Marketbeat Ratings reports. The brokerage issued a hold rating and a $19.00 target price on the stock.

Several other analysts also recently commented on the stock. Citigroup downgraded shares of RXO from a “buy” rating to a “neutral” rating and set a $33.00 price objective on the stock. in a research report on Tuesday, November 12th. Jefferies Financial Group dropped their price target on shares of RXO from $33.00 to $30.00 and set a “buy” rating on the stock in a report on Friday, January 10th. Morgan Stanley dropped their price target on shares of RXO from $27.00 to $25.00 and set an “equal weight” rating on the stock in a report on Thursday, February 6th. Stifel Nicolaus dropped their price target on shares of RXO from $27.00 to $24.00 and set a “hold” rating on the stock in a report on Thursday, February 6th. Finally, The Goldman Sachs Group dropped their price target on shares of RXO from $28.00 to $24.00 and set a “neutral” rating on the stock in a report on Thursday, February 6th. Two investment analysts have rated the stock with a sell rating, eleven have given a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $25.93.

Check Out Our Latest Stock Report on RXO

RXO Stock Performance

Shares of RXO stock opened at $19.83 on Friday. RXO has a one year low of $18.75 and a one year high of $32.82. The company’s 50-day moving average is $23.22 and its 200 day moving average is $26.26. The company has a market capitalization of $3.24 billion, a price-to-earnings ratio of -9.35, a price-to-earnings-growth ratio of 4.55 and a beta of 1.67. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.33 and a current ratio of 1.26.

RXO (NYSE:RXOGet Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $0.06 EPS for the quarter, meeting the consensus estimate of $0.06. RXO had a negative net margin of 6.26% and a positive return on equity of 1.53%. Sell-side analysts expect that RXO will post 0.31 EPS for the current fiscal year.

Institutional Investors Weigh In On RXO

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Blue Trust Inc. raised its stake in RXO by 79.7% during the 4th quarter. Blue Trust Inc. now owns 1,150 shares of the company’s stock worth $27,000 after acquiring an additional 510 shares during the period. Wilmington Savings Fund Society FSB bought a new stake in RXO during the 3rd quarter worth approximately $28,000. Smartleaf Asset Management LLC raised its stake in RXO by 228.4% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,248 shares of the company’s stock worth $30,000 after acquiring an additional 868 shares during the period. Nomura Asset Management Co. Ltd. raised its stake in RXO by 68.7% during the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 1,400 shares of the company’s stock worth $39,000 after acquiring an additional 570 shares during the period. Finally, Thurston Springer Miller Herd & Titak Inc. raised its stake in RXO by 407.0% during the 4th quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,800 shares of the company’s stock worth $43,000 after acquiring an additional 1,445 shares during the period. Institutional investors own 92.73% of the company’s stock.

About RXO

(Get Free Report)

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

Featured Articles

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.